论文信息 - Disease Biomarkers for Precision Medicine: Challenges and Future Opportunities - 字舞流文

Disease Biomarkers for Precision Medicine: Challenges and Future Opportunities

Siqi Liu | Edwin Wang | William C. S. Cho | S. C. Cesar Wong | Siqi Liu | W. Cho | S. C. Wong | Edwin Wang | S. Wong

[1] Jocelyn Kaiser. First Pass at Cancer Genome Reveals Complex Landscape , 2006, Science.

[2] Q. Cui,et al. Identification of high-quality cancer prognostic markers and metastasis network modules , 2010, Nature communications.

[3] David Venet,et al. Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome , 2011, PLoS Comput. Biol..

[4] E. Diamandis,et al. The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem? , 2012, BMC Medicine.

[5] Benjamin Haibe-Kains,et al. Significance Analysis of Prognostic Signatures , 2013, PLoS Comput. Biol..

[6] Laura M. Heiser,et al. A community effort to assess and improve drug sensitivity prediction algorithms , 2014, Nature Biotechnology.

[7] Nci Dream Community. A community effort to assess and improve drug sensitivity prediction algorithms , 2014 .

[8] J. Wolchok,et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. , 2014, The New England journal of medicine.

[9] E. Wang,et al. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. , 2014, Seminars in cancer biology.

[10] Jinfeng Zou,et al. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer. , 2016, JAMA oncology.